Seqirus to build £15m vaccine production facility in Liverpool
Flu vaccine provider Seqirus is to develop a £15.3m production facility at its manufacturing plant in Liverpool as part of a planned expansion of activity at the site.
Available to registered users only
To continue reading register for free today
Register today to get access to Propertyweek.com, the UK's number one source for commercial property news. As a registered user you are entitled to access four articles per month and you can also sign up for our newsletters. Get all of the latest industry news in one easy-to-access place.
If you are having problems using this form, go to http://www.propertyweek.com/register to register. If you are a subscriber, you can use the link in the top navigation to log in.
If you are registered for newsletters you can already access stories for FREE, enter your details here